EASI-75 interpretation from a patient perspective - a phase 2b post-hoc analysis of dupilumab in adults with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Poulin, Y. [1 ,2 ]
Tyring, S. [3 ,4 ]
Kimura, T. [5 ]
Andria, M. [5 ]
Ghorayeb, E. [6 ]
Eckert, L. [7 ]
Chao, J. [5 ]
机构：
[1] Ctr Rech Dermatol Quebec Metropolitain, Quebec City, PQ, Canada
[2] Univ Laval, Quebec City, PQ, Canada
[3] Univ Texas Hlth Sci Ctr Houston, Ctr Clin Studies, Houston, TX 77030 USA
[4] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA
[5] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[6] Sanofi, Cambridge, MA USA
[7] Sanofi, Chilly Mazarin, France
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [31] LEBRIKIZUMAB IMPROVES CLINICAL MANIFESTATIONS AND PATIENT-REPORTED OUTCOMES IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: PHASE 2B STUDY RESULTS
    Ali, Z.
    Guttman-Yassky, E.
    Blauvelt, A.
    Eichenfield, L.
    Paller, A.
    Armstrong, A.
    Drew, J.
    Gopalan, R.
    Simpson, E.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 32 - 32
  • [32] UPADACITINIB EFFECT ON PRURITUS IN MODERATE-TO-SEVERE ATOPIC DERMATITIS; FROM A PHASE 2B RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Beck, L.
    Hong, C.
    Hu, X.
    Chen, S.
    Calimlim, B.
    Teixeira, H.
    Guttman-Yassky, E.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S21 - S21
  • [33] Use of systemic therapy in adults with moderate-to-severe atopic dermatitis: analysis from the CorEvitas Atopic Dermatitis Registry
    Simpson, Eric L.
    Jones, Eric A.
    Cronin, Angel
    Dave, Swapna S.
    McLean, Robert R.
    Greenberg, Jeffrey
    Strober, Bruce
    Bieber, Thomas
    Gooderham, Melinda
    Paller, Amy S.
    Silverberg, Jonathan I.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E85 - E86
  • [34] Dupilumab in moderate-to-severe atopic dermatitis: results from two randomized phase 3 trials (SOLO 1 & 2)
    Simpson, E. L.
    Bieber, T.
    Guttman-Yassky, E.
    Beck, L. A.
    Blauvelt, A.
    Cork, M. J.
    Silverberg, J. I.
    Deleuran, M.
    Kataoka, Y.
    Lacour, J. -P.
    Kingo, K.
    Worm, M.
    Poulin, Y.
    Wollenberg, A.
    Soo, Y.
    Graham, N. M. H.
    Pirozzi, G.
    Akinlade, B.
    Staudinger, H.
    Mastey, V.
    Eckert, L.
    Gadkari, A.
    Ardeleanu, M.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 79 - 79
  • [35] Patient wellbeing and perception of treatment effect with long-term dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis
    Simpson, E. L.
    Beissert, S.
    Beck, L. A.
    Zhang, H.
    Aamodt, K.
    Rossi, A. B.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E139 - E139
  • [36] Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis from a phase 2b, randomized, controlled trial
    Guttman-Yassky, Emma
    Beck, Lisa A.
    Anderson, Jaclyn K.
    Hu, Xiaofei
    Gu, Yihua
    Teixeira, Henrique D.
    Silverberg, Jonathan I.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB294 - AB294
  • [37] Onset and maintenance of optimal itch response in adult patients with moderate-to-severe atopic dermatitis treated with dupilumab: post hoc analysis from LIBERTY AD CHRONOS
    Staender, Sonja
    Yosipovitch, Gil
    Simpson, Eric L.
    Kim, Brian S.
    Kabashima, Kenji
    Thaci, Diamant
    Metz, Martin
    Chen, Zhen
    Hagen, Sandra
    Bastian, Mike
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [38] Long-term efficacy of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis: a post hoc analysis of JADE EXTEND
    Paller, Amy S.
    Cork, Michael J.
    Flohr, Carsten
    Bangert, Christine
    Weidinger, Stephan
    Nesnas, John
    Farooqui, Saleem A.
    Biswas, Pinaki
    Watkins, Melissa
    Koppensteiner, Herwig
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [39] Rapid and sustained improvements in itch and sleep with tralokinumab treatment in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis of pooled data from ECZTRA 1 and 2
    Simpson, E.
    Wollenberg, A.
    Soong, W.
    Mark, T.
    Kuznetsova, A.
    Abildgaard-Steffensen, L.
    Silverberg, J. I.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E132 - E133
  • [40] Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
    Thaci, Diamant
    Simpson, Eric L.
    Beck, Lisa A.
    Bieber, Thomas
    Blauvelt, Andrew
    Papp, Kim
    Soong, Weily
    Worm, Margitta
    Szepietowski, Jacek C.
    Sofen, Howard
    Kawashima, Makoto
    Wu, Richard
    Weinstein, Steven P.
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Teper, Ariel
    Sutherland, E. Rand
    Mastey, Vera
    Stahl, Neil
    Yancopoulos, George D.
    Ardeleanu, Marius
    [J]. LANCET, 2016, 387 (10013): : 40 - 52
12345